Our strategy at a glance

Click to explore

Our focus

Our focus is on ‘fitting treatments to patients’: providing the right therapy for the right group of people at the right time. With Pharmaceuticals and Diagnostics under one roof and thanks to the strategic partnerships we have built, we are uniquely positioned to deliver personalised healthcare.

More

Our distinctiveness

In our pursuit of excellence in science, our distinctiveness rests on four key elements: deep understanding of molecular biology, seamless integration of our pharmaceutical and diagnostics capabilities, various approaches to maximise innovation, and long-term orientation.

More

Our delivery

Our delivery is to create value for all our stakeholders: being a partner of choice for patients, doctors, payers, employees, society and investors.

More

Our people

In the end, it takes people with integrity, courage and passion to make a difference for patients. It’s our people who are proud to say: We are Roche.

More

Our decision-making

Our decision-making principles and processes emphasise transparent dialogue, clear accountability and encourage a high degree of empowerment.

Our structure

Our structure is built for innovation. Our autonomous research and development centres and alliances with over 200 external partners foster diversity.

More

Our strategy at a glance

What we do

How we do it

Our focus

Our focus is on ‘fitting treatments to patients’: providing the right therapy for the right group of people at the right time. With Pharmaceuticals and Diagnostics under one roof and thanks to the strategic partnerships we have built, we are uniquely positioned to deliver personalised healthcare.

More

Our distinctiveness

In our pursuit of excellence in science, our distinctiveness rests on four key elements: deep understanding of molecular biology, seamless integration of our pharmaceutical and diagnostics capabilities, various approaches to maximise innovation, and long-term orientation.

More

Our delivery

Our delivery is to create value for all our stakeholders: being a partner of choice for patients, doctors, payers, employees, society and investors.

More

Our people

In the end, it takes people with integrity, courage and passion to make a difference for patients. It’s our people who are proud to say: We are Roche.

More

Our decision-making

Our decision-making principles and processes emphasise transparent dialogue, clear accountability and encourage a high degree of empowerment.

Our structure

Our structure is built for innovation. Our autonomous research and development centres and alliances with over 200 external partners foster diversity.

More

Value we create

27 million

patients treated with one of our top 25 medicines
  • 29 Roche medicines on the WHO List of Essential Medicines
  • 17+ billion tests conducted with Roche diagnostic instruments
  • 100+ new R&D partnerships in 2016
  • Ranked most sustainable healthcare company in the Dow Jones Sustainability Indices (DJSI) for the eighth year running

Value we create

... for patients

27

million patients treated with one of Roche’s top 25 medicines

128

million patients receiving treatment with Roche off-patent medicines

17

billion tests conducted with Roche Diagnostics products

74

new molecular entities in clinical development

29

Roche medicines on the WHO Essential Medicines List

More

Value we create

... for employees

94,052

employees** in over 100 countries

71%

employee engagement rate

41%

of women in management positions

44%

of international assignments to or from developing regions

0.064

accident rate

More

Value we create

... for partners

200+

R&D partnerships around the world

45%

of our pipeline come from partnered products

37%

of total pharmaceutical sales come from partnered and in-licensed products

100+

new R&D partnerships in 2016

~ 60,000

suppliers in over 80 countries

More

Value we create

... for the environment

9%

improvement in our eco balance since 2015

7%

improvement in energy efficiency since 2015

8%

improvement in CO2 efficiency since 2015

10%

decrease in water consumption since 2015

82%

of audit recommendations closed in 2016

More

Value we create

... for investors

CHF 50.6

billion in Group sales

CHF 9.9

billion invested in R&D

CHF 18.4

billion core operating profit

CHF 9.7

billion net income

CHF 14.53

core earnings per share

More